Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

Shingrix, which combined virus proteins with an immunity booster, prevented shingles in more than 90 percent of cases in clinical trials, with similar success in preventing nerve damage. It is now the ...

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...

An antibody that has the power to neutralise any influenza strain could be widely administered in the form of a nasal spray ...

Some periods of history are so bizarre that even if you’ve lived through them, looking back on them feels surreal, as though ...

The effectiveness of last season's COVID vaccines among immunocompetent adults reached 40% against hospitalization and 79% ...

Researchers at WashU Medicine have developed a nasal vaccine against the highly pathogenic H5N1 avian influenza virus, or bird flu, which has jumped from wild birds to livestock to humans.

New childhood vaccine recommendations from the US Centers for Disease Control and Prevention have been widely criticised by experts. Priya Venkatesan reports.

A new study has shown for the first time that an experimental vaccine against Middle East Respiratory Syndrome (MERS) induces ...

South Africa's battle against foot-and-mouth disease faces new challenges as the government warns that legal threats from agricultural lobby groups could undermine vaccine efforts and jeopardise the ...

An outbreak of the deadly Nipah virus in India’s West Bengal state has sparked concern in parts of Asia, with some tightening ...

Scientists have made the first step towards creating new species in the lab. Researchers have used artificial intelligence to ...